Microcarrier-Based Culture of Human Pluripotent Stem-Cell-Derived Retinal Pigmented Epithelium

Dry age-related macular degeneration (AMD) is estimated to impact nearly 300 million individuals globally by 2040. While no treatment options are currently available, multiple clinical trials investigating retinal pigmented epithelial cells derived from human pluripotent stem cells (hPSC-RPE) as a c...

Descripción completa

Detalles Bibliográficos

Autores principales:	Mohamed A. Faynus, Jeffrey K. Bailey, Britney O. Pennington, Mika Katsura, Duncan A. Proctor, Ashley K. Yeh, Sneha Menon, Dylan G. Choi, Jane S. Lebkowski, Lincoln V. Johnson, Dennis O. Clegg
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2022-07-01
Colección:	Bioengineering
Materias:	microcarriers stem cells retinal pigment epithelium
Acceso en línea:	https://www.mdpi.com/2306-5354/9/7/297
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!